Abstract
Patient-generated free-text messages are a well-recognized source of clinical burden and burnout for clinicians. Machine learning approaches such as Large Language Models (LLMs) may be applied to alleviate this burden by automatically triaging and classifying messages, but their performance in this domain has not been fully characterized. In this study, we analyzed the effectiveness of GPT4 for classifying patient and provider messages for hypertension management through prompt engineering, comparing its performance to an alternative unsupervised generative statistical approach. The results of this study suggest GPT is promising for classification of medical-related messages even with very few guiding examples.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This project was supported, in part, by a grant from the National Institute on Aging (grant P30-AG034546), which provided financial support for AD and TL. NSL was funded by the Department of Veterans Affairs through the National Clinician Scholars Program. DM received funding from the National Institutes of Health for this work (grant UL1-TR001878). We also want to extend our gratitude to the Penn Data and Analytics Center of Excellence for administering the secure Microsoft Azure Databricks environment for this study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was reviewed and approved by the University of Pennsylvania Institute Review Board.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Although this data has been de-identified prior to analysis, the data are not available.
